Marcy L'Etoile, France - April 21, 2011. Sales growth: 3.5% like-for-like
- Strong momentum in North America
- Temporary slowdown in China and India
- Robust growth in clinical microbiology
2011 sales growth objective confirmed at 5% to 6%
bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the three months ended March 31, 2011.
Net sales for the period reached €328 million, up a reported 6.8% from €307 million in first-quarter 2010. Growth amounted to 3.5% like-for-like (at constant exchange rates and scope of consolidation).
Download
- Filename
- biomerieux_pr_sales_q1_2011_en.pdf
- Size
- 58 KB
- Format
- application/pdf